BMP4 mediates the pathological activation of valvular interstitial cells and extracellular matrix remodeling in myxomatous mitral valve prolapse, identifying a potential molecular target for future therapies.
No takes yet. Share an insight, caveat, or question.
BMP4 may represent a therapeutic target in myxomatous MVP; leaves open whether pathway inhibition modifies disease in vivo.
Sainger et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: